Wangler2017 | R Documentation |
A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers. Global metabolic profiling obtained by untargetedmass spectrometry-based metabolomic platform for the detectionof novel and known inborn errors of metabolism. This untargeted approach collected z-score values for >650 unique compounds fromhuman plasma. Data set contains 19 individual plasma samples with confirmed biallelic pathogenic variants in the PEX1 gene. These samples revealed elevations in pipecolic acid and long-chain lysophosphatidylcholines, as well as an unanticipated reduction in multiple sphingomyelin species.
data(Wangler2017)
Wangler2017 - The data matrix (metabolite features are rows, patient observations are columns) for 19 untargeted metabolomics patient samples, alongside metabolite annotations.
Electronic supplementary material, Supplementary Tables (Dataset)
M.F. Wangler, et al. (2018). A metabolomic map of Zellweger spectrum disorders reveals novel disease biomarkers. Genetics in Medicine, 20: 1274-1283. <doi:10.1038/gim.2017.262>
data(Wangler2017)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.